Immune checkpoint expression score is an independent prognostic biomarker in resectable non-small cell lung cancer

被引:0
|
作者
Uso, Marta [1 ,2 ]
Jantus-Lewintre, Eloisa [2 ,3 ]
Sirera, Rafael [3 ]
Calabuig, Silvia [1 ,2 ]
Pastor, Enrique [4 ]
Forteza, Jeronimo [5 ]
Camps, Carlos [1 ,4 ]
机构
[1] Univ Valencia, Valencia, Spain
[2] Fdn Invest Hosp Gen Univ Valencia, Valencia, Spain
[3] Univ Politecn Valencia, E-46022 Valencia, Spain
[4] Hosp Gen Univ Valencia, Valencia, Spain
[5] Inst Valenciano Patol, Valencia, Spain
关键词
D O I
10.1158/1538-7445.AM2015-4330
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4330
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Immune checkpoint proteins as a prognostic biomarker of overall survival in non-small cell lung cancer: A meta-analysis and systematic review
    Tan, H. N.
    Rodriguez, C. C.
    Monte, K. A.
    Tan, P. G.
    Cornelio, G. D. H.
    ANNALS OF ONCOLOGY, 2020, 31 : S283 - S283
  • [42] Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer
    Mezquita, Laura
    Auclin, Edouard
    Ferrara, Roberto
    Charrier, Melinda
    Remon, Jordi
    Planchard, David
    Ponce, Santiago
    Paz Ares, Luis
    Leroy, Laura
    Audigier-Valette, Clarisse
    Felip, Enriqueta
    Zeron-Medina, Jorge
    Garrido, Pilar
    Brosseau, Solenn
    Zalcman, Gerard
    Mazieres, Julien
    Caramela, Caroline
    Lahmar, Jihene
    Adam, Julien
    Chaput, Nathalie
    Soria, Jean Charles
    Besse, Benjamin
    JAMA ONCOLOGY, 2018, 4 (03) : 351 - 357
  • [43] Modified Glasgow Prognostic Score Predict Survival Among Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
    Freitas, C.
    Tavares, N.
    Jacob, M.
    Mendonca, D.
    Oliveira, P.
    Araujo, D.
    Novais-Bastos, H.
    Fernandes, G.
    Magalhaes, A.
    Queiroga, H.
    Hespanhol, V.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S464 - S464
  • [44] Prognostic impact of the high-sensitivity modified Glasgow prognostic score in patients with resectable non-small cell lung cancer
    Osugi, Jun
    Muto, Satoshi
    Matsumura, Yuki
    Higuchi, Mitsunori
    Suzuki, Hiroyuki
    Gotoh, Mitsukazu
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (02) : 945 - 951
  • [45] Prognostic effect of cachexia in patients with non-small cell lung cancer receiving immune checkpoint inhibitors
    Matsuo, Norikazu
    Azuma, Koichi
    Murotani, Kenta
    Murata, Daiki
    Matama, Goushi
    Kawahara, Akihiko
    Kojima, Takashi
    Tokito, Takaaki
    Hoshino, Tomoaki
    THORACIC CANCER, 2023, 14 (15) : 1362 - 1367
  • [46] Efficacy and Prognostic Factors of Immune Checkpoint Inhibitors in the Treatment of Advanced Non-small Cell Lung Cancer
    Hu, Yu-xiong
    Guo, Li-jing
    Lin, Meng-qing
    Lin, Qing-yu
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2023, 46 (04): : 161 - 166
  • [47] Prognostic Value of Immune Cell Biomarkers in Surgically Resectable Non-Small Cell Lung Cancer: A Meta-Analysis
    Tuminello, S.
    Veluswamy, R.
    Lieberman-Cribbin, W.
    Gnjatic, S.
    Petralia, F.
    Wang, P.
    Flores, R.
    Van Gerwen, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S612 - S613
  • [48] MGA Mutation as a Novel Biomarker for Immune Checkpoint Therapies in Non-Squamous Non-Small Cell Lung Cancer
    Sun, Lei
    Li, Man
    Deng, Ling
    Niu, Yuchun
    Tang, Yichun
    Wang, Yu
    Guo, Linlang
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [49] Advances in clinical trials on perioperative immune checkpoint inhibitors for resectable non-small cell lung cancer: A comprehensive review
    Cui, Siyuan
    Wang, Na
    Liang, Yangyueying
    Meng, Yuan
    Shu, Xinyi
    Kong, Fanming
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 141
  • [50] Exosomal PD-L1 expression as non-invasive biomarker for immune checkpoint inhibitors in non-small cell lung cancer
    Gunasekaran, Muthukumar
    Russo, Alessandro
    Cardona, Andres F.
    Perez, Diego de Miguel
    Lapidus, Rena
    Cooper, Brandon
    Kaushal, Sunjay
    Adamo, Vincenzo
    Rolfo, Christian
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):